Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases

View ORCID ProfileJialiang Yang, Bin Zhang, Sander Houten, Eric Schadt, Jun Zhu, Yousin Suh, Zhidong Tu
doi: https://doi.org/10.1101/326264
Jialiang Yang
1Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jialiang Yang
Bin Zhang
1Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sander Houten
1Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Schadt
1Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Zhu
1Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yousin Suh
3Department of Genetics, Albert Einstein College of Medicine, New York City, New York, United States of America
4Department of Medicine Endocrinology, Albert Einstein College of Medicine, New York City, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhidong Tu
1Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhidong.tu@mssm.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

A key goal of geroscience research is to discover effective interventions to extend human healthspan, the years of healthy life. Currently, majority of the geroprotectors are found by testing compounds in model organisms; whether these compounds will be effective in humans is largely unknown. Here we present a novel strategy called ANDRU (aging network based drug discovery) to help the discovery of human geroprotectors. Instead of relying on model organisms, this approach is driven by human genomic and pharmacogenomic data. It first identifies human aging subnetworks that putatively function at the interface between aging and age-related diseases; it then screens for pharmacological or genetic interventions that may “reverse” the age-associated transcriptional changes seen in these subnetworks. We applied ANDRU to human adipose and artery tissues. In adipose tissue, PTPN1, a target for diabetes treatment and APOE, a known genetic factor for human longevity and diseases like Alzheimer’s disease, were ranked at the top. For small molecules, conjugated linoleic acid and metformin, a drug commonly used to treat type 2 diabetes, were ranked among the top compounds. In artery tissue, N-methyl-D-aspartate antagonists and curcumin were ranked at the top. In summary, ANDRU represents a promising human data-driven strategy that may speed up the discovery of interventions to extend human healthspan.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 19, 2018.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases
Jialiang Yang, Bin Zhang, Sander Houten, Eric Schadt, Jun Zhu, Yousin Suh, Zhidong Tu
bioRxiv 326264; doi: https://doi.org/10.1101/326264
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases
Jialiang Yang, Bin Zhang, Sander Houten, Eric Schadt, Jun Zhu, Yousin Suh, Zhidong Tu
bioRxiv 326264; doi: https://doi.org/10.1101/326264

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Systems Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (2533)
  • Biochemistry (4975)
  • Bioengineering (3486)
  • Bioinformatics (15229)
  • Biophysics (6908)
  • Cancer Biology (5395)
  • Cell Biology (7751)
  • Clinical Trials (138)
  • Developmental Biology (4539)
  • Ecology (7157)
  • Epidemiology (2059)
  • Evolutionary Biology (10233)
  • Genetics (7516)
  • Genomics (9790)
  • Immunology (4860)
  • Microbiology (13231)
  • Molecular Biology (5142)
  • Neuroscience (29464)
  • Paleontology (203)
  • Pathology (838)
  • Pharmacology and Toxicology (1465)
  • Physiology (2142)
  • Plant Biology (4754)
  • Scientific Communication and Education (1013)
  • Synthetic Biology (1338)
  • Systems Biology (4014)
  • Zoology (768)